Clinical Trial Update: Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor [Phase 2]

View source ↗

Summary

Phase 2 trial assessing cisplatin or carboplatin with gemcitabine for locally advanced, recurrent, or metastatic malignant salivary gland tumors in head and nec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Malignant Salivary Gland Tumor

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED